StockNews.com Downgrades Maximus (NYSE:MMS) to Hold

Maximus (NYSE:MMS) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday.

Separately, Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd.

Maximus Stock Up 0.0 %

Shares of NYSE MMS opened at $67.19 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.49 and a debt-to-equity ratio of 0.82. Maximus has a 12-month low of $66.52 and a 12-month high of $93.97. The firm’s 50-day moving average price is $74.22 and its 200-day moving average price is $82.73. The stock has a market capitalization of $3.80 billion, a price-to-earnings ratio of 14.45 and a beta of 0.72.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities research analysts anticipate that Maximus will post 6.05 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Michelle F. Link sold 2,208 shares of the business’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total transaction of $163,016.64. Following the completion of the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $484,841.61. The trade was a 25.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Raymond B. Ruddy purchased 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The stock was bought at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the purchase, the director now directly owns 112,520 shares in the company, valued at $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 7,063 shares of company stock valued at $502,017 over the last 90 days. Insiders own 1.60% of the company’s stock.

Institutional Trading of Maximus

Several institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock worth $488,829,000 after purchasing an additional 205,564 shares during the period. Geode Capital Management LLC grew its position in shares of Maximus by 1.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider’s stock worth $142,109,000 after buying an additional 21,532 shares in the last quarter. Van Berkom & Associates Inc. increased its stake in shares of Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock valued at $93,792,000 after buying an additional 98,264 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Maximus by 7.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider’s stock valued at $74,700,000 after acquiring an additional 71,598 shares in the last quarter. Finally, Norges Bank purchased a new stake in Maximus in the fourth quarter worth about $71,443,000. Institutional investors own 97.21% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.